Status:
COMPLETED
Modified Intermittent Fasting in Psoriasis
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
University Ghent
Conditions:
Psoriasis Vulgaris
Psoriasis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The complexity of psoriasis is partially affected by dietary effects, and some diets have shown to be beneficial in psoriasis. Intermittent fasting has been shown to improve many of these disturbances...
Detailed Description
To study the role of gut health, more specifically the intestinal barrier, in individuals with psoriasis and the effects of fasting on both organs in a prospective cohort cross-over study. The investi...
Eligibility Criteria
Inclusion
- Mild psoriasis (PASI \< 10)
- At least BMI of 20
- Stable weight for last 3 months
- Topical treatment
- Availability of smartphone and willing to install app
- Willing to attend dematology clinic at Ghent University Hospital
Exclusion
- Underweight and/or following strict diet
- Use of anti, pre and/or probiotics (last 3 months)
- Use of immunosuppressants (last 3 months)
- Smoking
- Consumption of fish oil
- Diagnosed diabetes (type ½)
- Excessive physical activity
- Pregnancy or breastfeeding
- More than 14 alcohol units/week
- History of cardiac condition(s)
Key Trial Info
Start Date :
October 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04418791
Start Date
October 17 2020
End Date
February 23 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Head & Skin
Ghent, East-Flanders, Belgium, 9000